Establishing routine early on helps proactively manage adverse effects associated with CDK4/6 inhibitors, says Kimberly ...

Panelists discuss the importance of vigilant, patient-centered monitoring for metastatic melanoma patients with high disease ...

Panelists discuss the critical role of patient education and multidisciplinary coordination in managing immunotherapy side ...

Paolo Tarantino, MD, PhD, explains that the chemotherapy-related toxicities from an ADC are more likely to limit dosage for ...

The addition of retifanlimab to chemotherapy increased progression-free survival in patients with advanced squamous cell ...

Panelists discuss updated MonumenTAL-1 trial data demonstrating high response rates and prolonged survival with ...

While CIML natural killer immunotherapy can result in infection-like reactions, required prior chemo may cause infections, ...

Panelists discuss how a 48-year-old fitness instructor with ALK-rearranged stage IV lung cancer and bone metastases was ...

Patients receiving subcutaneous daratumumab have less chair time and premedication than those receiving IV formulation, says ...

Panelists discuss how patients newly diagnosed with multiple myeloma often face emotional and informational overload, but ...

Panelists discuss how patient portal use improves communication by allowing patients to report adverse effects with photos ...

Panelists discuss updated safety findings from GPRC5D-targeted bispecific therapy in relapsed/refractory multiple myeloma, ...